Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital

References

• Rasmussen E, Bindslev-Jensen C, Bygum A. Angioedema – assessment and treatment. Tidsskr nor Legeforen. 2012;20(20):2391–2395. doi:10.4045/tidsskr.12.0470
   Google Scholar
• Mansi M, Zanichelli A, Coerezza A, et al. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med. 2015;277(5):585–593. doi:10.1111/joim.1230425196353
   PubMed Web of Science ®Google Scholar
• Champion RH, Roberts SOB, Carpenter RG, Roger JH. Urticaria and angio-oedema. Br J Dermatol. 1969;81(81):588–597. doi:10.1111/j.1365-2133.1969.tb16041.x5801331
   PubMed Web of Science ®Google Scholar
• Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175(9):1065–1070. doi:10.1503/cmaj.06053517060655
   PubMed Web of Science ®Google Scholar
• Kibsgaard L, Lefevre AC, Deleuran M, Vestergaard C. A case series study of eighty-five chronic spontaneous urticaria patients referred to a tertiary care center. Ann Dermatol. 2014;26(1):73–78. doi:10.5021/ad.2014.26.1.7324648689
   PubMed Web of Science ®Google Scholar
• Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59(May):8–13. doi:10.1016/j.ejim.2018.09.00430220453
   PubMed Web of Science ®Google Scholar
• Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the hereditary angioedema international working group. Eur J Allergy Clin Immunol. 2014;69(5):602–616. doi:10.1111/all.12380
   Google Scholar
• Bafunno V, Firinu D, D’Apolito M, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141(3):1009–1017. doi:10.1016/j.jaci.2017.05.02028601681
   PubMed Web of Science ®Google Scholar
• Bork K, Wulff K, Steinmüller-Magin L, et al. Hereditary angioedema with a mutation in the plasminogen gene. Eur J Allergy Clin Immunol. 2018;73(2):442–450. doi:10.1111/all.13270
   Google Scholar
• Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286–1289. doi:10.1016/j.bbrc.2006.03.09216638441
   PubMed Web of Science ®Google Scholar
• Bork K, Wulff K, Rossmann H, et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin. Allergy Eur J Allergy Clin Immunol. 2019;74(12):2479–2481. doi:10.1111/all.13869
   Web of Science ®Google Scholar
• Zanichelli A, Arcoleo F, Barca MP, et al. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015;10(1):11. doi:10.1186/s13023-015-0233-x25758562
   PubMed Web of Science ®Google Scholar
• Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009;161(5):1153–1158. doi:10.1111/j.1365-2133.2009.09366.x19709101
   PubMed Web of Science ®Google Scholar
• Gobert D, Paule R, Ponard D, et al. A nationwide study of acquired C1-inhibitor deficiency in France. Medicine (Baltimore). 2016;95(33):e4363. doi:10.1097/MD.000000000000436327537564
   PubMed Web of Science ®Google Scholar
• Bygum A, Vestergaard H. Acquired angioedema – Occurrence, clinical features and associated disorders in a Danish nationwide patient cohort. Int Arch Allergy Immunol. 2013;162(2):149–155. doi:10.1159/00035145223921495
   PubMed Web of Science ®Google Scholar
• Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. Survey review the kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005;38(1):6–38. doi:10.1254/jphs.SRJ05001X
   Web of Science ®Google Scholar
• Hirschy RA, Shah T, Davis T, Rech MA. Treatment of life-threatening ACE-inhibitor-induced angioedema. Adv Emerg Nurs J. 2018;40(4):267–277. doi:10.1097/TME.000000000000021130365440
   PubMed Web of Science ®Google Scholar
• Crochet J, Lepelley M, Yahiaoui N, et al. Bradykinin mechanism is the main responsible for death by isolated asphyxiating angioedema in France. Clin Exp Allergy. 2018;49(September 2018):252–254. doi:10.1111/cea.1329730326160
   PubMed Web of Science ®Google Scholar
• Prior N, Remor E, Pérez-Fernández E, et al. Psychometric field study of hereditary angioedema quality of life questionnaire for adults: HAE-QoL. J Allergy Clin Immunol Pract. 2016;4(3):464–473. doi:10.1016/j.jaip.2015.12.01026969268
   PubMed Web of Science ®Google Scholar
• Nedelea I, Deleanu D. Isolated angioedema: an overview of clinical features and etiology (review). Exp Ther Med. 2018;17(4):1068–1072. doi:10.3892/etm.2018.698230679975
   PubMed Web of Science ®Google Scholar
• Bork K, Staubach-Renz P, Hardt J. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate. Orphanet J Rare Dis. 2019;143(2):AB42.
   Google Scholar
• Craig T, Zuraw B, Longhurst H, et al. Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2019;7(6):1793–1802.e2. doi:10.1016/j.jaip.2019.01.05430772477
   PubMed Web of Science ®Google Scholar
• Cicardi M, Banerji ABF, Malbrán A, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532–541. doi:10.1056/NEJMoa090639320818888
   PubMed Web of Science ®Google Scholar
• Sundhedsdatastyrelsen. Medstat.dk [Internet]. [cited 320, 2019]. Available from: http://www.medstat.dk.
   Google Scholar
• Christensen AI, Ekholm O, Davidsen M, Juel K. Sundhed Og Sygelighed 2010. 2010.
   Google Scholar
• Kragh-Jakobsen AS, Haun Jesper B. Hjertesvigt [Internet]. [cited 42, 2019]. Available from: http://www.hjertesvigt.dk.
   Google Scholar
• Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010;6(1):1–5. doi:10.1186/1710-1492-6-1420298513
   PubMedGoogle Scholar
• Holm JPY, Ovesen T. Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema. Dan Med J. 2012;59(6):A4449.22677247
   PubMed Web of Science ®Google Scholar
• Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637–1642. doi:10.1001/archinte.165.14.163716043683
   PubMedGoogle Scholar
• Banerji A, Blumenthal KG, Lai KH, Zhou L. Epidemiology of ACE inhibitor angioedema utilizing a large electronic health record. J Allergy Clin Immunol Pract. 2017;5(3):744–749. doi:10.1016/j.jaip.2017.02.01828377081
   PubMed Web of Science ®Google Scholar
• Rasmussen ER, Pottegård A, Bygum A, von Buchwald C, Homøe P, Hallas J. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors – a nationwide registry-based cohort study. J Intern Med. 2019;285(5):1–9. doi:10.1111/joim.12867
   Web of Science ®Google Scholar
• Kaplan AP. Angioedema. World Allergy Organ J. 2008;1(6):103–113. doi:10.1097/WOX.0b013e31817aecbe23282406
   PubMedGoogle Scholar
• Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol. 2010;24(6):685–691. doi:10.1111/j.1468-3083.2009.03489.x19925599
   PubMed Web of Science ®Google Scholar
• Kulthanan K, Jiamton S, Boochangkool K, Jongjarearnprasert K. Angioedema: clinical and etiological aspects. Clin Dev Immunol. 2007;2007:6–11. doi:10.1155/2007/26438
   Google Scholar
• El Mekki AB, Chaib A, Kombich J. Drug induced angioedema: a rare side effect of simvastatin. Pan Afr Med J. 2017;26(7):213. doi:10.11604/pamj.2017.26.38.1031228690728
   PubMedGoogle Scholar
• Kuruvilla ME, Sanan N. Amlodipine-induced angioedema: an unusual complication of a common medication. Allergy Rhinol. 2018;6(9):1–2.
   Google Scholar
• Atik D, Büyükcam F, Yılmaz D, Işık B, Demir ÖF. Angioedema after the first dose of metformin. Am J Emerg Med. 2013;31(3):634.e5. doi:10.1016/j.ajem.2012.10.021
   Web of Science ®Google Scholar
• Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest. 1994;106(6):1922–1923. doi:10.1378/chest.106.6.19227988234
   PubMed Web of Science ®Google Scholar
• Tai S, Mascaro M, Goldstein NA. Angioedema: a review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol. 2010;119(12):836–841. doi:10.1177/00034894101190120821250556
   PubMed Web of Science ®Google Scholar
• Madsen F, Attermann J, Linneberg A. Epidemiology of non-hereditary angioedema. Acta Derm Venereol. 2012;92(5):475–479. doi:10.2340/00015555-138922791189
   PubMed Web of Science ®Google Scholar
• Eli M, Joseph M, Kuznik B, Menachem S. Chronic idiopathic angioedema: a single center experience. Int J Dermatol. 2014;53(10):e421–7. doi:10.1111/ijd.1260125209993
   PubMed Web of Science ®Google Scholar
• Megerian CA, Arnold JE, Berger M. Angioedema: 5 years’ experience, with a review of the disorder’s presentation and treatment. Laryngoscope. 1992;(102):256–260.1545652
   PubMed Web of Science ®Google Scholar
• Kim SJ, Brooks JC, Sheikh J, Kaplan MS, Goldberg BJ. Angioedema deaths in the United States, 1979–2010. Ann Allergy Asthma Immunol. 2014;113(6):630–634. doi:10.1016/j.anai.2014.09.00325280464
   PubMed Web of Science ®Google Scholar
• Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc. 2000;75(11):1201–1204. doi:10.4065/75.11.120111075752
   PubMed Web of Science ®Google Scholar
• Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol. 2008;101(2):185–192. doi:10.1016/S1081-1206(10)60208-618727475
   PubMed Web of Science ®Google Scholar
• Baş M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor–induced angioedema. N Engl J Med. 2015;372(5):418–425. doi:10.1056/NEJMoa131252425629740
   PubMed Web of Science ®Google Scholar
• Cicardi M, Bergamaschini L, Zingale LC, Gioffré D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med. 1999;106(6):650–654. doi:10.1016/S0002-9343(99)00123-010378623
   PubMed Web of Science ®Google Scholar
• Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Int Arch Allergy Immunol. 2014;165(2):119–127. doi:10.1159/00036840425401373
   PubMed Web of Science ®Google Scholar
• Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor–induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017;5(5):1402–1409.e3. doi:10.1016/j.jaip.2017.03.00328552382
   PubMed Web of Science ®Google Scholar
• Straka B, Ramirez C, Byrd J, et al. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. 2017;140(1):242–248.e2. doi:10.1016/j.jaci.2016.09.05127913306
   PubMed Web of Science ®Google Scholar
• Greve J, Bas M, Hoffmann TK, et al. Effect of C1-esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2015;125(6):E198–202. doi:10.1002/lary.2511325583256
   PubMed Web of Science ®Google Scholar
• Bas M. Randomized, double-blind, two arms, multicenter, phase III study of berinert for treatment of ACE induced angioedema [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01843530?term=complement+C1&cond=Angioedema&cntry=DE&rank=3. Accessed 622, 2020.
   Google Scholar